We focus on the science of the immune system and advanced technologies, investing in 4 core therapeutic areas (respiratory, immunology and inflammation; oncology; HIV; and infectious diseases) to impact health at scale. We operate responsibly for all our stakeholders by prioritising Innovation, Performance and Trust.

Our Portfolio:

• Specialty Medicines: Our specialty medicines prevent and treat diseases, from HIV, cancer and asthma to immune-inflammation diseases like lupus.
• Vaccines: Our broad vaccines portfolio targets infectious diseases at every stage of life.
• General Medicines: From antibiotics to inhaled medicines for asthma and COPD, we have a broad portfolio of general medicine products, many of them leaders in their class, making life better for millions of people worldwide.